Parallel Solutions, Inc. Company Profile

05:14 EST 16th December 2018 | BioPortfolio

Parallel Solutions, Inc. (PSI) is a Research and Development company based in Cambridge, Massachusetts. PSI specializes in the development of novel polyphosphazene polymers and the application and commercialization of these polymers in the field of life sciences.
Polyphosphazenes are a unique class of polymers consisting of an inorganic phosphorous-nitrogen backbone and reactive pendant side groups. Polyphosphazenes are constructed by initially creating a polymer backbone and then substitutiting reactive side groups with chosen building blocks through methods of organic chemistry.Polyphosphazenes are differentiated by their:
Tremendous synthetic versatility
Tunable hydrolytic degradability
High thermal and oxidative stability
Broad range of mechanical characteristics
PSI is developing a number of unique compounds suited to high value applications in the life science.PSI's first applications are a suite of immunomodulators for use in vaccines and immunotherapeutics, and non-convalent polyphosphazene based approaches to the delivery of therapeutic protiens.


763, Concord AvenueBuilding D
United States of America


Phone: (617) 876-2178
Fax: (617) 876-0728

News Articles [315 Associated News Articles listed on BioPortfolio]

Custom High Pressure Parallel Reactors

Proven in numerous installations worldwide, the Asynt High Pressure Parallel Reactor can be custom configured to optimally suit applications including homogeneous and heterogeneous catalysis, hydrogen...

Higher Administrative Court of North Rhine-Westphalia rules on liability of German parallel importer for violation of (local) distribution law by a pharmaceutical wholesaler in another EU Member State.

Prècis Parallel imports of medicines are, in principle, permitted within the EU. In particular, the price differences in different countries for medicines are the economic driver of parallel im...

Asynt offers new custom High Pressure Parallel Reactor

Proven in numerous installations worldwide, the Asynt High Pressure Parallel Reactor can be custom configured to optimally suit applications including homogeneous and heterogeneous catalysis, hydrogen...

Divestment of mature pharmaceutical products in the EU – implications for parallel imports

Précis In the forty-three years since the UK acceded to the European Union, a large body of case law has developed in the Court of Justice of the EU and national courts dealing with parallel tr...

Simple Safe Parallel Reaction Sampling

Asynt has introduced the DrySyn OCTO Mini Conversion Kit to enable chemists to efficiently sample reactions performed using their DrySyn OCTO 8-position parallel synthesiser. ...

Bringing European Parallel Programming Technology to the Exascale Era

NewsThe EPEEC has received 3.9 million euros ($4.4 million) in funding to develop and deploy a production-ready parallel programming environment.

Hard Brexit could wipe out UK’s parallel trade in pharmaceuticals

A hard Brexit would eliminate the UK’s parallel pharmaceutical distribution market, according to legal counsel to the British Association of European Pharmaceutical Distributors.

High Pressure Parallel Reactors

Product AnnouncementThe Asynt High Pressure Parallel Reactor can be configured to suit many applications.Contributed Author: 

PubMed Articles [646 Associated PubMed Articles listed on BioPortfolio]

Parallel consolidation into visual working memory results in reduced precision representations.

Information can be consolidated into visual working memory in parallel, i.e. two items can be consolidated in the same time required to consolidate one. However, while motion direction items consolida...

copMEM: Finding maximal exact matches via sampling both genomes.

Genome-to-genome comparisons require designating anchor points, which are given by Maximum Exact Matches (MEMs) between their sequences. For large genomes this is a challenging problem and the perform...

Equalizer 2.0 - Convergence of a Parallel Rendering Framework.

Developing complex, real world graphics applications which leverage multiple GPUs and computers for interactive 3D rendering tasks is a complex task. It requires expertise in distributed systems and p...

Effects of long-term treatment with low-GDP, pH-neutral solutions on peritoneal membranes in peritoneal dialysis patients.

The morphological changes induced by bio-incompatible peritoneal dialysis (PD) solutions are well known. However, the morphological damage induced by long-term low-glucose degradation product (GDP), p...

A straightforward method for measuring the range of apparent density of microplastics.

Density of microplastics has been regarded as the primary property that affect the distribution and bioavailability of microplastics in the water column. For measuring the density of microplastis, we ...

Clinical Trials [2242 Associated Clinical Trials listed on BioPortfolio]

A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone

To compare the effectiveness of a 90-day Copaxone® adherence enhancement program for a sample of MS patients who are at high risk of nonadherence and receive support from Shared Solutions...

TOnicity of Perioperative Maintenance SoluTions

Prospective randomized double blind phase IV trial studying the efficacy and safety of the tonicity of two different perioperative maintenance solutions: an isotonic solution containing Na...

Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness

Obesity is increasing at an alarming rate in patients with schizophrenia, possibly in association with the increased use of atypical antipsychotics. In order to address the weight and meta...

Palatability of Oral Rehydration Solutions

The primary objective of this study is to compare the mean taste scores for three fruit flavored oral rehydration solutions in children aged 5-10 years old. The secondary objective is to ...

Safety and Efficacy of MBI 226 2.5% and 5.0% Topical Acne Solutions in the Treatment of Acne

This study investigates the safety and efficacy of MBI 226 2.5% and 5.0% Acne Solutions, applied topically for six weeks, in the treatment of acne.

Companies [1384 Associated Companies listed on BioPortfolio]

InnovaSyn, LLC

InnovaSyn sells the SynthArray-6 and SynthArray-24 parallel synthesis reactors.Solution phase parallel synthesis is a valuable technique for both lead generation and lead optimization and should not b...

Parallel 6

Parallel 6, an innovator in enterprise cloud-based technologies, enables customer engagement and real-time data insights. Clinical Reach, a Parallel 6 product, enables clinical...

Chemspeed Technologies

Chemspeed Technologies AG focuses on delivering full workflow solutions and providing application-oriented training and support as well as product integration. A leading team of scientists, with seven...

Parallel Solutions, Inc.

Parallel Solutions, Inc. (PSI) is a Research and Development company based in Cambridge, Massachusetts. PSI specializes in the development of novel polyphosphazene polymers and the application and com...


Cradlepoint is the global leader in cloud-delivered 4G LTE networking solutions, providing secure business-grade connectivity to distributed enterprises with hundreds or thousands...

More Information about "Parallel Solutions, Inc." on BioPortfolio

We have published hundreds of Parallel Solutions, Inc. news stories on BioPortfolio along with dozens of Parallel Solutions, Inc. Clinical Trials and PubMed Articles about Parallel Solutions, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Parallel Solutions, Inc. Companies in our database. You can also find out about relevant Parallel Solutions, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record